TECX
NASDAQ
US
Tectonic Therapeutic, Inc. - Common Stock
$30.52
▼ $-0.26
(-0.84%)
Vol 163K
3
Quality Score
fail
Rev ✗
NI ✗
>IPO ✗
Mkt Cap
$390.4M
ROE
-27.1%
D/E
0.19
Beta
1.64
52W
$14–$61
Wall Street Consensus
15 analysts · Apr 20264
Strong Buy
10
Buy
1
Hold
0
Sell
0
Strong Sell
93.3%
Buy Rating
Price Chart
Similar Stocks
PRME
Prime Medicine Inc
$626.4M
OCGN
Ocugen Inc
$421.6M
MDXG
MiMedx Group Inc
P/E 24.6
$1.0B
IRWD
Ironwood Pharmaceuticals Inc
P/E 19.2
$548.2M
PROK
Prokidney Corp
$673.9M
KYTX
Kyverna Therapeutics Inc
$537.0M
EIKN
Eikon Therapeutics Inc
CBIO
Crescent Biopharma Inc
$164.8M
ZURA
Zura Bio Ltd
$340.7M
UPB
Upstream Bio Inc
$1.5B
Earnings
Beat rate: 75.0%| Quarter | EPS Est | EPS Act | Surprise |
|---|---|---|---|
| Dec 2025 | $-1.13 | $-1.03 | +$0.10 |
| Sep 2025 | $-1.07 | $-1.02 | +$0.05 |
| Jun 2025 | $-1.00 | $-1.07 | $-0.07 |
| Mar 2025 | $-1.11 | $-0.93 | +$0.18 |
Fundamentals Trend
| Metric | 2025-06-30 | 2025-09-02 | 2025-10-02 | 2025-11-03 | 2025-12-03 | 2026-01-02 |
|---|---|---|---|---|---|---|
| ROE (TTM) | -30.1% | -30.1% | -30.1% | -30.1% | -27.1% | -27.1% |
| P/E (TTM) | — | — | — | — | — | — |
| Net Margin | — | — | — | — | — | — |
| Gross Margin | — | — | — | — | — | — |
| D/E Ratio | 0.22 | 0.22 | 0.22 | 0.22 | 0.19 | 0.19 |
| Current Ratio | 25.60 | 25.60 | 25.60 | 25.60 | 29.15 | 29.15 |
Key Ratios
ROA (TTM)
-25.9%
P/B
4.8
EPS (TTM)
$-3.85
52W High
$61.07
52W Low
$13.70
$13.70
52-Week Range
$61.07
How does TECX compare to Biotechnology peers?
Peer group: Micro-cap Biotechnology (All) · 528 companies
TECX valuation vs Biotechnology peers
P/E ratio
—
▼
0%
below
peers
(18.8)
vs Peers
vs Industry
Undervalued
P/S ratio
—
▼
0%
below
peers
(12.9)
vs Peers
vs Industry
Overvalued
P/B ratio
4.8
▲
97%
above
peers
(2.5)
vs Peers
vs Industry
Overvalued
Div yield
—
▼
0%
below
peers
(0.0%)
vs Peers
vs Industry
Low yield
TECX profitability vs Biotechnology peers
ROE
-27.1%
▲
60%
above
peers
(-67.3%)
vs Peers
vs Industry
Top tier
Net margin
—
▼
0%
below
peers
(-286.8%)
vs Peers
vs Industry
Top tier
Gross margin
—
▼
0%
below
peers
(78.6%)
vs Peers
vs Industry
In line
ROA
-25.9%
▲
45%
above
peers
(-46.7%)
vs Peers
vs Industry
Top tier
TECX financial health vs Biotechnology peers
D/E ratio
0.2
▼
0%
below
peers
(0.0)
vs Peers
vs Industry
In line
Current ratio
29.2
▲
557%
above
peers
(4.4)
vs Peers
vs Industry
Strong liquidity
Beta
1.6
▲
69%
above
peers
(1.0)
vs Peers
vs Industry
More volatile
TECX fundamentals radar
TECX
Peer median
Industry
TECX profitability vs leverage
Bubble size = market cap · X = net margin · Y = D/E ratio
TECX vs peers: key metrics
Latest News
No related news yet